Analysts' Upgrades, Downgrades: Eli Lilly

CHANGE IN RATINGS

Archer-Daniels-Midland (ADM Quote) downgraded at Citigroup from Hold to Sell. $25 price target. Deteriorating trends will likely become evident at the upcoming earnings report.

Ansys (ANSS Quote) downgraded at JPMorgan to Neutral from Overweight. Following recent 52% rally, company will likely have to deliver results at high end of guidance range to maintain high multiple. Remain bullish long-term, but would look for better entry point. Price target at $27.50.

Cabot (CBT Quote) downgraded at JPMorgan to Underweight from Neutral. Believe earnings will remain under pressure over next several quarters due to declining volumes of rubber black, tantalum and fumed metal oxides. Additional restructuring may be needed if fundamentals do not turn around. Price target at $8.

Cullen/Frost Bankers (CFR Quote) downgraded at Oppenheimer to Underperform. Economy is beginning to deteriorate in Texas, and the stock has outperformed its peers over the past year. ...